Public Profile

Beike Biotechnology Co., Ltd.

Beike Biotechnology Co., Ltd., commonly referred to as Beike Biotech, is a leading player in the biotechnology sector, headquartered in China. Established in 2005, the company has made significant strides in regenerative medicine, focusing on innovative cell therapies and advanced medical solutions. With a strong presence in major operational regions across Asia and beyond, Beike Biotech is renowned for its unique offerings, including umbilical cord blood stem cell therapies and personalised treatment plans. These core products stand out due to their commitment to safety and efficacy, positioning the company as a trusted name in the industry. Recognised for its pioneering research and development, Beike Biotech continues to achieve notable milestones, solidifying its market position as a frontrunner in the field of regenerative medicine.

DitchCarbon Score

How does Beike Biotechnology Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

20

Industry Average

Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

4

Industry Benchmark

Beike Biotechnology Co., Ltd.'s score of 20 is higher than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.

51%

Beike Biotechnology Co., Ltd.'s reported carbon emissions

Beike Biotechnology Co., Ltd., headquartered in China, currently does not have available carbon emissions data for recent years, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is unclear how the company is addressing its carbon footprint or contributing to climate action. In the absence of concrete data, it is essential to monitor industry trends and best practices in sustainability to understand the broader context of Beike Biotechnology's potential climate commitments.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Beike Biotechnology Co., Ltd.'s primary industry is Other business services (74), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Beike Biotechnology Co., Ltd. is headquartered in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Beike Biotechnology Co., Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Fangdd Network Group Ltd.

CN
Computer and related services (72)
Updated 2 days ago

Beijing Lianjia Real Estate Brokerage Co., Ltd.

CN
Real estate services (70)
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers